Lazard Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $67K | Sell |
|
|||||
|
2025
Q1 | $1.45M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $806K | Sell |
|
|||||
|
2023
Q1 | $1.23M | Sell |
|
|||||
|
2022
Q4 | $1.79M | Sell |
|
|||||
|
2022
Q3 | $2.48M | Sell |
|
|||||
|
2022
Q2 | $66.8M | Buy |
|
|||||
|
2022
Q1 | $66K | Buy |
|
|||||
|
2021
Q4 | $4K | Hold |
|
|||||
|
2021
Q3 | $3K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.66M | Sell |
|
|||||
|
2020
Q4 | $2.98M | Sell |
|
|||||
|
2020
Q3 | $5.66M | Sell |
|
|||||
|
2020
Q2 | $6.35M | Buy |
|